Kenneth H. Kraemer

Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers

Sikandar G. Khan, H. Fassihi, D. Tamura, 2023, Frontiers in oncology.